GlassScriptPhysician profile
Tamara Guichard
NPI 1053372698
$5,014.58
in general payments reported to CMS, 2019-2025
34 companies · $879 in 2025
The $879 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $370 · 2021: $624 · 2022: $1,176 · 2023: $681 · 2024: $1,021 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,567 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,566.66 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.64 | 2019-2024 | |
| Evofem Biosciences, INC. | $468.35 | 2020-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $452.81 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $432.15 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $330.07 | 2021-2025 | |
| Daiichi Sankyo INC. | $308.28 | 2024-2025 | Injectafer |
| Urovant Sciences INC | $224.29 | 2021-2022 | |
| Avion Pharmaceuticals | $154.97 | 2021-2023 | Balcoltra |
| Terumo Medical Corporation | $150.71 | 2022 | |
| Hologic Sales and Service, LLC | $132.01 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Scynexis, INC. | $129.47 | 2022 | |
| Myovant Sciences INC. | $128.49 | 2021-2022 | |
| Lupin INC. | $117.28 | 2019-2020 | |
| Therapeuticsmd, INC. | $115.38 | 2022 | |
| Coopersurgical, INC. | $109.10 | 2021-2025 | Paragard T 380a, Paragard T 380a |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $106.22 | 2022-2024 | |
| Smith+Nephew, INC. | $104.65 | 2023-2024 | Collagenase Santyl |
| Exeltis, USA INC. | $103.02 | 2024-2025 | Slynd |
| Acerus Pharmaceuticals Corporation | $96.23 | 2021-2022 | |
| Organon LLC | $93.92 | 2023-2025 | Nexplanon |
| Millicent US INC | $79.32 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Antares Pharma, INC. | $64.30 | 2022 | |
| Boston Scientific Corporation | $64.08 | 2019-2023 | Varithena Administration Pack |
| Janssen Biotech, INC. | $61.61 | 2022-2023 | Erleada |
| Agile Therapeutics, INC. | $60.24 | 2023-2024 | Twirla |
| Mylan Pharmaceuticals INC. | $58.99 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $30.00 | 2020 | |
| Zyla Life Sciences, INC. | $24.48 | 2020 | |
| Allergan, INC. | $23.54 | 2021 | |
| Teleflex LLC | $23.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.41 | 2020 | |
| Genentech USA, INC. | $17.63 | 2021 | |
| Currax Pharmaceuticals LLC | $14.06 | 2024 | Contrave |
| Dysis Medical, INC. | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Guichard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.